Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Arora

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Journal of Clinical and Experimental Hepatology|November 8, 2019
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data SystemSonal Krishan, Radha K Dhiman, Navin Kalra, et al.
Journal of Clinical and Experimental Hepatology|June 19, 2025
Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLDAjay Duseja, Arka De, Shivaram P Singh, et al.
Scientific Reports|March 9, 2024
Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patientsKessarin Thanapirom, Sombat Treeprasertsuk, Ashok Choudhury, et al.
Journal of Clinical and Experimental Hepatology|March 23, 2023
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)Ajay Duseja, S P Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology|March 8, 2021
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the LiverPankaj Puri, Radha K Dhiman, Sunil Taneja, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in IndiaPankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology|February 7, 2020
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II RecommendationsAshish Kumar, Subrat K Acharya, Shivaram P Singh, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in IndiaPankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology|February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) StudyNarendra S Choudhary, Ajay Duseja, Arka De, et al.
Journal of Clinical and Experimental Hepatology|December 18, 2023
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III RecommendationsAshish Kumar, Subrat K Acharya, Shivaram P Singh, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Journal of Clinical and Experimental Hepatology|November 8, 2019
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data SystemSonal Krishan, Radha K Dhiman, Navin Kalra, et al.
Journal of Clinical and Experimental Hepatology|June 19, 2025
Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLDAjay Duseja, Arka De, Shivaram P Singh, et al.
Scientific Reports|March 9, 2024
Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patientsKessarin Thanapirom, Sombat Treeprasertsuk, Ashok Choudhury, et al.
Journal of Clinical and Experimental Hepatology|March 23, 2023
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)Ajay Duseja, S P Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology|March 8, 2021
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the LiverPankaj Puri, Radha K Dhiman, Sunil Taneja, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in IndiaPankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology|February 7, 2020
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II RecommendationsAshish Kumar, Subrat K Acharya, Shivaram P Singh, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in IndiaPankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology|February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) StudyNarendra S Choudhary, Ajay Duseja, Arka De, et al.
Journal of Clinical and Experimental Hepatology|December 18, 2023
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III RecommendationsAshish Kumar, Subrat K Acharya, Shivaram P Singh, et al.
Pageof 13